The role of postoperative Tc-99m pertechnetate scintigraphy in estimation of remnant mass and prediction of successful ablation in patients with differentiated thyroid cancer

被引:18
|
作者
Ozdemir, Didem [1 ]
Cuhaci, Fatma N. [1 ]
Ozdemir, Elif [2 ]
Aydin, Cevdet [1 ]
Ersoy, Reyhan [1 ]
Turkolmez, Seyda [2 ]
Cakir, Bekir [1 ]
机构
[1] Ankara Yildirim Beyazit Univ, Dept Endocrinol & Metab, Sch Med, TR-06800 Ankara, Turkey
[2] Ankara Yildirim Beyazit Univ, Sch Med, Dept Nucl Med, Ankara, Turkey
关键词
ablation; differentiated thyroid cancer; postoperative remnant; Tc-99m pertechnetate scintigraphy; VASCULAR RETENTION; CARCINOMA; PAPILLARY;
D O I
10.1097/MNM.0000000000000492
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective Surgery and radioactive iodine (RAI) ablation constitute the mainstay of the treatment of differentiated thyroid carcinoma (DTC). In this study, we aimed to evaluate the diagnostic value of postoperative early Tc-99m pertechnetate scanning to detect remnant thyroid tissue and predict ablation success. Methods DTC patients evaluated with postoperative Tc-99m pertechnetate scintigraphy and treated with RAI between January 2007 and December 2014 were recruited. The results of Tc-99m pertechnetate scanning were compared with therapeutic I-131 whole-body scanning (TxWBS) and diagnostic I-131 whole-body scanning (DxWBS) performed 6-9 months after RAI. Results There were 154 (21.5%) male and 563 (78.5%) female patients, with a mean age of 49.11 +/- 12.35 years. Postoperative Tc-99m pertechnetate scanning was positive in 499 patients (69.6%) and negative in 218 (30.4%) patients. There were 673 (93.9%) patients with a positive TxWBS scan and 44 (6.1%) patients with negative TxWBS scan. Considering TxWBS as the standard test, sensitivity, specificity, positive predictive value, and negative predictive value of Tc-99m pertechnetate scanning were 72.2, 70.5, 97.4, and 14.2%, respectively. DxWBS was positive in 57 (9.0%) and negative in 564 (91%) patients. Ablation dose was higher and preablation thyroglobulin was lower in patients with negative DxWBS (P = 0.001 and 0.04, respectively). Overall, 171 (92.9%) of 184 patients with negative Tc-99m pertechnetate had negative DxWBS. Conclusion Postoperative Tc-99m pertechnetate scintigraphy has a high positive predictive value to detect remnant tissue in patients with DTC. Although negative Tc-99m pertechnetate scanning does not indicate removal of all thyroid tissue, it is related to successful ablation in more than 90% of patients. Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.
引用
收藏
页码:640 / 645
页数:6
相关论文
共 50 条
  • [41] Tc-99m bone scan vs Tc-99m PSMA scintigraphy in advanced metastatic prostate cancer patients
    Rathke, Hendrik
    Giesel, Frederik
    Flechsig, Paul
    Haufe, Sabine
    Haberkorn, Uwe
    Kratochwil, Clemens
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [42] TC-99M PERTECHNETATE UPTAKE, AND THYROID SCAN APPEARANCES IN 102 PATIENTS WITH SPONTANEOUS HYPOTHYROIDISM
    BROWNLIE, BEW
    SMITH, A
    ELLWOOD, M
    ROGERS, TGH
    TURNER, JG
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1981, 11 (05): : 578 - 578
  • [43] "No remnant thyroid tissue" on Tc-99m pertechnetate scan, can we trust it? Comparison with I-123 scan and correlation with ablation success
    Chong, Ari
    Song, Ho-chun
    Yoo, Su Woong
    Jung-Min, Ha
    Kang, Sae-Ryung
    Oh, Jong-Ryool
    Byun, Byung Hyun
    Hong, Sun-Pyo
    Min, Jung-Joon
    Bom, Hee-Seung
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [44] Prediction of the success of thyroid remnant ablation using preablative 99mTc pertechnetate scintigraphy and postablative dual 131I scintigraphy
    Jung, Jo Sung
    Lee, Sang Mi
    Kim, Sang Jin
    Choi, Jiyoun
    Han, Sun Wook
    NUCLEAR MEDICINE COMMUNICATIONS, 2015, 36 (01) : 38 - 44
  • [45] MORE ON [TC-99M] (V)DMSA SCINTIGRAPHY IN PATIENTS WITH MEDULLARY CARCINOMA OF THE THYROID
    MOJIMINIYI, OA
    UDELSMAN, R
    SHEPSTONE, BJ
    DUDLEY, NE
    SOPER, NDW
    JOURNAL OF NUCLEAR MEDICINE, 1989, 30 (08) : 1420 - 1420
  • [46] The role of Tc-99m MIBI scintigraphy in the management of patients with pulmonary tuberculosis
    Raziei, G.
    Taghizadeh, R.
    Javadi, H.
    Assadi, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S411 - S411
  • [47] Whole-body Tc-99m sestamibi scintigraphy in the follow-up of differentiated thyroid carcinoma
    Almeida, P
    Ravizzini, GC
    Almeida, C
    Borges-Neto, S
    CLINICAL NUCLEAR MEDICINE, 2000, 25 (06) : 443 - 446
  • [48] PER-RECTAL PORTAL SCINTIGRAPHY WITH TC-99M PERTECHNETATE IN PATIENTS WITH ORTHOTOPIC LIVER-TRANSPLANT
    DARIENZO, A
    CELENTANO, L
    CIMINO, L
    PARRILLI, G
    MANGUSO, F
    SULLO, P
    BUDILLON, G
    MAZZACCA, G
    GASTROENTEROLOGY, 1995, 108 (04) : A1056 - A1056
  • [49] Decreased thyroid uptake of Tc-99m pertechnetate in patients with advanced-stage Sjogren syndrome evaluation using salivary gland scintigraphy
    Taura, SI
    Murata, Y
    Aung, W
    Ishida, R
    Zhang, L
    Hossain, M
    Takahashi, Y
    Okada, N
    Shibuya, H
    CLINICAL NUCLEAR MEDICINE, 2002, 27 (04) : 265 - 269
  • [50] Thyroid imaging with Tc-99m MIBI in patients with solitary cold single nodules on pertechnetate imaging
    Alonso, O
    Lago, G
    Mut, F
    Hermida, JC
    Nunez, M
    DePalma, G
    Touya, E
    CLINICAL NUCLEAR MEDICINE, 1996, 21 (05) : 363 - 367